Vericel Corp. (VCEL)
35.13
-1.65
(-4.49%)
USD |
NASDAQ |
May 07, 16:00
35.13
0.00 (0.00%)
After-Hours: 19:28
Vericel Free Cash Flow : 24.75M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -12.01M |
| Arbutus Biopharma Corp. | -39.72M |
| Tenaya Therapeutics, Inc. | -68.88M |
| Moderna, Inc. | -1.603B |
| Anavex Life Sciences Corp. | -34.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 15.01M |
| Cash from Investing (Quarterly) | -16.39M |
| Cash from Financing (Quarterly) | 1.065M |
| Free Cash Flow Per Share (Quarterly) | 0.2463 |
| Free Cash Flow to Equity (Quarterly) | 14.36M |
| Free Cash Flow to Firm (Quarterly) | 12.98M |
| Free Cash Flow Yield | 1.38% |